The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. I ...

Our previous study indicated that BCR/ABL SH2 domain and BCR/ABL SH3 domain+SH2 domain complex are required for immediate activation of the phosphatidylinositol-3 kinase PI-3k)→ Akt serine ...

PARIS, May 19, 2025--(BUSINESS WIRE)--Genethon unveiled the 2-year follow-up data from its GNT0004 gene therapy clinical ... or stabilization of motor functions and significant persistent ...

The Alliance for Regenerative Medicine’s (ARM) Cell & Gene Meeting on the Med, took place in Barcelona back in April. ABL Biomanufacturing - a pure play Contract Development and Manufacturing ...

Cite this: Abl Tyrosine Kinase Inhibitors for Overriding Bcr-Abl/T315I: From the Second to Third Generation - Medscape - Sep 01, 2008.

May 14, 2025 • Trump's win exposed political tensions between Arab-American voters — who were critical of Democratic support of Israel's war in Gaza, and Black voters — who remain the ...

The digital revolution has already reshaped the commercial engine of biopharma companies. Pharma’s digital initiatives now routinely enable new channels that educate and market to patients ...

A new gene therapy targeting the heart protein cBIN1 reversed heart failure and restored heart function in pigs, showing unprecedented recovery and a 30% improvement in heart performance. If ...

Gene function, including that of coding and non-coding genes, can be difficult to identify in molecular wet laboratories. Therefore, computational methods, often including machine learning, may be a ...

2023). Lian et al., 2021 reports their study on miR-140 directly target PINK1 gene and reduce its expression. PINK1 enhances mitochondrial function and cognition according to the previous studies.